The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
T-Cell Lymphomas
US$ 189.99
(+ tax)
Preview (read now)
Add to my own site
Give this ebook to a friend
Add to my wishlist
Author's page
Publisher's page
Devices
- iPad
- PC
- e-readers with Adobe Digital Editions installed
- Mac
See the full list
Available Devices
X
This book is available for the following devices:
- iPad
- Windows
- Mac
- Sony Reader
- Cool-er Reader
- Nook
- Kobo Reader
- iRiver Story
File Formats
Download: secure PDF.
You can also read this book online in eb20 format without having to download anything.
You can also read this book online in eb20 format without having to download anything.
Permissions
Printing
Copy/Paste
Read Aloud
Printing
Copy/Paste
Read Aloud
more
The mature T and NK cell lymphomas are rare, comprising approximately 10 per cent of all malignant lymphomas. The incidence of T-cell lymphoma is variable around the world, with a higher incidence compared to B-cell lymphomas in the Asian basin. While the overall incidence of B-cell lymphomas has begun to decline in the United States, the incidence of T-cell lymphomas continues to rise. Over the last decade, a number of novel agents have been developed which target T-cell lymphomas and studies have identified novel genes and pathways associated with lymphomagenesis in T-cells. This comprehensive volume examines the clinical and biological aspects of the T-cell lymphoproliferative disorders in adults and children. The book includes an overview of both the cutaneous and the systemic T-cell malignancies and addresses the classification of T-cell lymphomas, the clinical features of each subtype, and the relevant molecular and genetic studies. Clinical outcomes and treatment strategies are discussed with an emphasis on the development of novel biological and targeted therapies.An outstanding resource for hematologists and oncologists, this book gathers insights from experts in the field and provides the most up-to-date information on all of the T-cell lymphoma subgroups and current and emerging therapies.
less